These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1259 related articles for article (PubMed ID: 6219841)

  • 1. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
    Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
    J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
    Kornstein MJ; Brooks JS; Elder DE
    Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
    Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibodies.
    Meijer CJ; de Graaff-Reitsma CB; Lafeber GJ; Cats A
    J Rheumatol; 1982; 9(3):359-65. PubMed ID: 6981702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.
    Czernielewski J; Faure M; Schmitt D; Thivolet J
    Clin Exp Immunol; 1982 Nov; 50(2):426-33. PubMed ID: 6217936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
    Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
    Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Halo nevus. In situ study using monoclonal antibodies].
    Vignale RA; Paciel J; Bruno J; Calandría L; de Anda G
    Med Cutan Ibero Lat Am; 1986; 14(1):13-7. PubMed ID: 2942737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of major histocompatibility antigens and the mononuclear cell infiltrate in halo nevi.
    Bergman W; Willemze R; de Graaff-Reitsma C; Ruiter DJ
    J Invest Dermatol; 1985 Jul; 85(1):25-9. PubMed ID: 3159801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK; DesMarais CL
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic dynamics of tumor progression in human malignant melanoma.
    Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
    Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
    Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
    Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined immunohistological and histochemical analysis of lymphocyte and macrophage subpopulations in the rheumatoid nodule.
    Duke OL; Hobbs S; Panayi GS; Poulter LW; Rasker JJ; Janossy G
    Clin Exp Immunol; 1984 May; 56(2):239-46. PubMed ID: 6375915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human macrophages and T-lymphocyte subsets infiltrating nodules of Onchocerca volvulus.
    Parkhouse RM; Bofill M; Gomez-Priego A; Janossy G
    Clin Exp Immunol; 1985 Oct; 62(1):13-8. PubMed ID: 3905094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas.
    García-Plata D; Lessana-Leibowitch M; Palangie A; Gulliemette J; Sedel D; Méndez L; Mozos E
    Invasion Metastasis; 1995; 15(3-4):125-34. PubMed ID: 8621268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
    López-Nevot MA; Garcia E; Romero C; Oliva MR; Serrano S; Garrido F
    Exp Clin Immunogenet; 1988; 5(4):203-12. PubMed ID: 3078572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.